Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 2
1983 2
1985 1
1986 2
1990 3
1991 3
1993 2
1994 1
1995 2
1996 4
1997 2
1998 5
1999 8
2000 6
2001 3
2002 2
2003 2
2004 1
2005 5
2006 5
2007 6
2008 10
2009 9
2010 9
2011 5
2012 3
2013 3
2014 4
2015 9
2016 9
2017 6
2018 15
2019 13
2020 13
2021 10
2022 14
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

188 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial.
Laffel LM, Danne T, Klingensmith GJ, Tamborlane WV, Willi S, Zeitler P, Neubacher D, Marquard J; DINAMO Study Group. Laffel LM, et al. Among authors: zeitler p. Lancet Diabetes Endocrinol. 2023 Mar;11(3):169-181. doi: 10.1016/S2213-8587(22)00387-4. Epub 2023 Feb 1. Lancet Diabetes Endocrinol. 2023. PMID: 36738751 Free PMC article. Clinical Trial.
Long-Term Complications in Youth-Onset Type 2 Diabetes.
TODAY Study Group; Bjornstad P, Drews KL, Caprio S, Gubitosi-Klug R, Nathan DM, Tesfaldet B, Tryggestad J, White NH, Zeitler P. TODAY Study Group, et al. Among authors: zeitler p. N Engl J Med. 2021 Jul 29;385(5):416-426. doi: 10.1056/NEJMoa2100165. N Engl J Med. 2021. PMID: 34320286 Free PMC article.
Once-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes.
Arslanian SA, Hannon T, Zeitler P, Chao LC, Boucher-Berry C, Barrientos-Pérez M, Bismuth E, Dib S, Cho JI, Cox D; AWARD-PEDS Investigators. Arslanian SA, et al. Among authors: zeitler p. N Engl J Med. 2022 Aug 4;387(5):433-443. doi: 10.1056/NEJMoa2204601. Epub 2022 Jun 4. N Engl J Med. 2022. PMID: 35658022 Clinical Trial.
They're still kids.
Zeitler PS, Klingensmith GJ. Zeitler PS, et al. J Pediatr. 2009 Jan;154(1):7-9. doi: 10.1016/j.jpeds.2008.09.028. J Pediatr. 2009. PMID: 19187730 No abstract available.
Insulin Resistance of Puberty.
Kelsey MM, Zeitler PS. Kelsey MM, et al. Among authors: zeitler ps. Curr Diab Rep. 2016 Jul;16(7):64. doi: 10.1007/s11892-016-0751-5. Curr Diab Rep. 2016. PMID: 27179965 Review.
188 results